Skip to main content
. 1998 May;72(5):4427–4429. doi: 10.1128/jvi.72.5.4427-4429.1998

FIG. 2.

FIG. 2

Ability of mutant Cap-Pols to support ScVM1. Cytoduction assays were performed as described in Materials and Methods to assay replicase and transcriptase activities of mutant versions of the ScV Cap-Pol. About 100 cytoductants derived from each mutant were tested for the killer phenotype. C, negative control (vector without cDNA insert); WT, wild-type positive control (unmodified ScV Cap-Pol). 1 to 8, mutants carrying GlV-ScV motif swaps in regions 1 to 8.